BAYSTRIDE, INC – Trademark Portfolio
Entity Type: 03
BAYSTRIDE, INC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 31 (Natural Agricultural Products) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include LANDSPATH, THERADIET, WELLSTRIDE, and RAYNE CLINICAL NUTRITION. The owner is based in Leawood, KS.
13105 Cedar Street
Leawood, KS 66209
Showing of trademarks Trademarks
Trademark Classifications
BAYSTRIDE, INC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does BAYSTRIDE, INC have?
BAYSTRIDE, INC has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.
What trademark classes does BAYSTRIDE, INC file in?
BAYSTRIDE, INC files trademarks across 4 Nice Classification classes. The most active classes are Class 31 (Natural Agricultural Products), Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 40 (Treatment & Processing). Class 31 covers raw and unprocessed agricultural, aquacultural, horticultural and forestry products.
What are BAYSTRIDE, INC's most well-known trademarks?
BAYSTRIDE, INC's registered trademark portfolio includes well-known marks such as LANDSPATH, THERADIET, WELLSTRIDE, and RAYNE CLINICAL NUTRITION. These are among 5 currently registered trademarks in the portfolio.
What is BAYSTRIDE, INC's trademark registration success rate?
BAYSTRIDE, INC has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.